Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021L06)
Received: 5 September 2022
Accepted: 20 July 2023
First Online: 3 August 2023
: Institutional review board approval was obtained for the ISRT-NPC trial from the ethics committee of the Cancer Hospital, Chinese Academy of Medical Sciences (reference number 22/107-3308). The ISRT-NPC trial is published under NCT05145660 on ClinicalTrials.gov. Written informed consent will be obtained from all participants included in the study prior to randomization.
: Not applicable.
: The authors declare that they have no competing interests.